InDevR: InDevR raises $9 million in series B financing and partners with bioMrieux

InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, and bioMérieux - a worldwide leader in in vitro diagnostics and microbiological quality control solutions for the food and pharmaceutical industries - $5 million. Together, these investments will support InDevR's commercial expansion and ongoing development of new reagent kits for its VaxArray® platform...